-
1
-
-
0033006836
-
Cancer statistics, 1999
-
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
-
(1999)
CA Cancer J Clin
, vol.49
, pp. 8-31
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
6044262405
-
Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India
-
Yeole BB, Kumar AV, Kurkure A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev 2004;5:308-15.
-
(2004)
Asian Pac J Cancer Prev
, vol.5
, pp. 308-315
-
-
Yeole, B.B.1
Kumar, A.V.2
Kurkure, A.3
Sunny, L.4
-
3
-
-
11844278537
-
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
-
Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005;113:977-90.
-
(2005)
Int J Cancer
, vol.113
, pp. 977-990
-
-
Bray, F.1
Loos, A.H.2
Tognazzo, S.3
La Vecchia, C.4
-
4
-
-
18144395073
-
Ovarian cancer incidence in the United States, 1992-1999
-
Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005;97:519-23.
-
(2005)
Gynecol Oncol
, vol.97
, pp. 519-523
-
-
Quirk, J.T.1
Natarajan, N.2
-
5
-
-
0000958776
-
Ovarian cancer, fallopian tube carcinoma and peritoneal carcinoma
-
DeVita VT Jr, Hellman S, Rosenberg SA, Editors. Williams and Wilkins: Lippincott
-
th ed. Williams and Wilkins: Lippincott; 2001. p. 1597-632.
-
(2001)
th Ed.
, pp. 1597-1632
-
-
Ozols, R.F.1
Schwartz, P.E.2
Eifel, P.J.3
-
6
-
-
0033936074
-
Ovarian cancer: Epidemiology, biology and prognostic factors
-
Holschneider CH, Berek JS. Ovarian cancer: Epidemiology, biology and prognostic factors. Semin Surg Oncol 2000;19:3-10.
-
(2000)
Semin Surg Oncol
, vol.19
, pp. 3-10
-
-
Holschneider, C.H.1
Berek, J.S.2
-
7
-
-
0033971373
-
The epidemiology of ovarian cancer: A population-based study in Olmsted County, Minnesota, 1935-1991
-
Beard CM, Hartmann LC, Atkinson EJ, O'Brien GD, Malkasian GD, Keeney GL, et al. The epidemiology of ovarian cancer: A population-based study in Olmsted County, Minnesota, 1935-1991. Ann Epidemiol 2000;10:14-23.
-
(2000)
Ann Epidemiol
, vol.10
, pp. 14-23
-
-
Beard, C.M.1
Hartmann, L.C.2
Atkinson, E.J.3
O'Brien, G.D.4
Malkasian, G.D.5
Keeney, G.L.6
-
8
-
-
0027525996
-
Surgical staging and cytoreductive surgery of epithelial ovarian cancer
-
Hoskins WJ. Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993;71:1534-40.
-
(1993)
Cancer
, vol.71
, pp. 1534-1540
-
-
Hoskins, W.J.1
-
9
-
-
0028237380
-
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
-
Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-80.
-
(1994)
Am J Obstet Gynecol
, vol.170
, pp. 974-980
-
-
Hoskins, W.J.1
McGuire, W.P.2
Brady, M.F.3
Homesley, H.D.4
Creasman, W.T.5
Berman, M.6
-
10
-
-
0036498788
-
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
-
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FL. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002;20:1248-59.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1248-1259
-
-
Bristow, R.E.1
Tomacruz, R.S.2
Armstrong, D.K.3
Trimble, E.L.4
Montz, F.L.5
-
12
-
-
0025125086
-
The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma
-
Fioretti P, Gadducci A, Del Bravo B, Prato B. The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma. Eur J Gynaecol Oncol 1990;11:175-9.
-
(1990)
Eur J Gynaecol Oncol
, vol.11
, pp. 175-179
-
-
Fioretti, P.1
Gadducci, A.2
Del Bravo, B.3
Prato, B.4
-
13
-
-
0038162281
-
Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
-
Mazzeo F, Berliere M, Kerger J, Squiflett J, Duck L, D'Hondt V, et al. Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol 2003;90:163-9.
-
(2003)
Gynecol Oncol
, vol.90
, pp. 163-169
-
-
Mazzeo, F.1
Berliere, M.2
Kerger, J.3
Squiflett, J.4
Duck, L.5
D'Hondt, V.6
-
14
-
-
0028952438
-
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer
-
van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favelli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer. N Engl J Med 1995;332:629-34.
-
(1995)
N Engl J Med
, vol.332
, pp. 629-634
-
-
Van Der Burg, M.E.1
Van Lent, M.2
Buyse, M.3
Kobierska, A.4
Colombo, N.5
Favelli, G.6
-
15
-
-
18344391714
-
The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer
-
Pectasides D, Farmakis D, Koumarianou A. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer. Oncology 2005;68:64-70.
-
(2005)
Oncology
, vol.68
, pp. 64-70
-
-
Pectasides, D.1
Farmakis, D.2
Koumarianou, A.3
-
16
-
-
0032422162
-
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
-
Vergote I, De Wever I, Tjalma W, Van Grambaren M, Decloidt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients. Gynecol Oncol 1998;71:431-6.
-
(1998)
Gynecol Oncol
, vol.71
, pp. 431-436
-
-
Vergote, I.1
De Wever, I.2
Tjalma, W.3
Van Grambaren, M.4
Decloidt, J.5
Van Dam, P.6
-
17
-
-
3042823262
-
The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma
-
Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 2004;101:346-52.
-
(2004)
Cancer
, vol.101
, pp. 346-352
-
-
Dowdy, S.C.1
Mullany, S.A.2
Brandt, K.R.3
Huppert, B.J.4
Cliby, W.A.5
-
18
-
-
0028828287
-
Ovarian cancer: Staging with CT and MR imaging
-
Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL. Ovarian cancer: Staging with CT and MR imaging. Radiology 1995;197:619-26.
-
(1995)
Radiology
, vol.197
, pp. 619-626
-
-
Forstner, R.1
Hricak, H.2
Occhipinti, K.A.3
Powell, C.B.4
Frankel, S.D.5
Stern, J.L.6
-
20
-
-
0027394686
-
Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma
-
Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-72.
-
(1993)
J Clin Oncol
, vol.11
, pp. 166-172
-
-
Nelson, B.E.1
Rosenfield, A.T.2
Schwartz, P.E.3
-
21
-
-
12344325535
-
Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer
-
Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 2005;96:301-6.
-
(2005)
Gynecol Oncol
, vol.96
, pp. 301-306
-
-
Qayyum, A.1
Coakley, F.V.2
Westphalen, A.C.3
Hricak, H.4
Okuno, W.T.5
Powell, B.6
-
22
-
-
0242608855
-
Ovaries and fallopian tubes
-
nd ed.: Churchill Livingston
-
nd ed. Clinical Oncology: Churchill Livingston; 2000. p. 2020-35.
-
(2000)
Clinical Oncology
, pp. 2020-2035
-
-
Thigpen, J.T.1
-
23
-
-
0019961380
-
Cyclophosphamide plus CIS-platinum in combination: Treatment program for stage III or IV ovarian carcinoma
-
Decker DG, Fleming TR, Malkasian GD Jr, Webb MJ, Jeffries JA, Edmonson JH. Cyclophosphamide plus CIS-platinum in combination: Treatment program for stage III or IV ovarian carcinoma. Obstet Gynecol 1982;60:481-7.
-
(1982)
Obstet Gynecol
, vol.60
, pp. 481-487
-
-
Decker, D.G.1
Fleming, T.R.2
Malkasian Jr., G.D.3
Webb, M.J.4
Jeffries, J.A.5
Edmonson, J.H.6
-
24
-
-
0021285620
-
Randomized trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma
-
Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Vriesendorp R, Kooyman CD, et al. Randomized trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Lancet 1984;2:594-600.
-
(1984)
Lancet
, vol.2
, pp. 594-600
-
-
Neijt, J.P.1
Ten Bokkel Huinink, W.W.2
Van Der Burg, M.E.3
Van Oosterom, A.T.4
Vriesendorp, R.5
Kooyman, C.D.6
-
25
-
-
0024506224
-
Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A gynecologic oncology group study
-
Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A gynecologic oncology group study. J Clin Oncol 1989;7:457-65.
-
(1989)
J Clin Oncol
, vol.7
, pp. 457-465
-
-
Omura, G.A.1
Bundy, B.N.2
Berek, J.S.3
Curry, S.4
Delgado, G.5
Mortel, R.6
-
26
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
-
(1996)
N Engl J Med
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
-
27
-
-
0026589291
-
A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report
-
Kjorstad K, Harris A, Bertelsen K, Slevin M, Shultz H, Hellman K, et al. A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report. Ann Oncol 1992;3:217-22.
-
(1992)
Ann Oncol
, vol.3
, pp. 217-222
-
-
Kjorstad, K.1
Harris, A.2
Bertelsen, K.3
Slevin, M.4
Shultz, H.5
Hellman, K.6
-
28
-
-
0027055485
-
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma
-
Einzig AI, Wiernik PH, Sasloff J, Runowicz CD, Goldberg GL. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 1992;10:1748-53.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1748-1753
-
-
Einzig, A.I.1
Wiernik, P.H.2
Sasloff, J.3
Runowicz, C.D.4
Goldberg, G.L.5
-
29
-
-
0642333855
-
Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
-
Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, et al. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg 2003;197:955-63.
-
(2003)
J Am Coll Surg
, vol.197
, pp. 955-963
-
-
Morice, P.1
Dubernard, G.2
Rey, A.3
Atallah, D.4
Pautier, P.5
Pomel, C.6
-
30
-
-
0028283281
-
Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer
-
Guidozzi F, Ball JH. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 1994;53:326-30.
-
(1994)
Gynecol Oncol
, vol.53
, pp. 326-330
-
-
Guidozzi, F.1
Ball, J.H.2
-
31
-
-
0035201884
-
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer
-
Gillette-Cloven N, Burger RA, Monk BJ, McMeeken DS, Vasilev S, DiSaia PJ, et al. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 2001;193:626-32.
-
(2001)
J Am Coll Surg
, vol.193
, pp. 626-632
-
-
Gillette-Cloven, N.1
Burger, R.A.2
Monk, B.J.3
McMeeken, D.S.4
Vasilev, S.5
DiSaia, P.J.6
-
32
-
-
1942462676
-
The role of interval debulking surgery in ovarian cancer
-
Gynecological Cancer Group of the EORTC
-
van der Burg ME, Vergote I; Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep 2003;5:473-81.
-
(2003)
Curr Oncol Rep
, vol.5
, pp. 473-481
-
-
Van Der Burg, M.E.1
Vergote, I.2
-
33
-
-
0035889879
-
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
-
Kuhn W, Rutke S, Spathe K, Schmalfeldt B, Florack G, von Hundelshausen B, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 2001;92:2585-91.
-
(2001)
Cancer
, vol.92
, pp. 2585-2591
-
-
Kuhn, W.1
Rutke, S.2
Spathe, K.3
Schmalfeldt, B.4
Florack, G.5
Von Hundelshausen, B.6
-
34
-
-
15744406047
-
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma
-
Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 2005;103:1397-401.
-
(2005)
Cancer
, vol.103
, pp. 1397-1401
-
-
Eitan, R.1
Levine, D.A.2
Abu-Rustum, N.3
Sonoda, Y.4
Huh, J.N.5
Franklin, C.C.6
-
35
-
-
0026648619
-
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma
-
Goodman HM, Harlow BL, Sheets EE, Mooto MG, Brooks S, Stellar M, et al. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol 1992;46:367-71.
-
(1992)
Gynecol Oncol
, vol.46
, pp. 367-371
-
-
Goodman, H.M.1
Harlow, B.L.2
Sheets, E.E.3
Mooto, M.G.4
Brooks, S.5
Stellar, M.6
|